Merck & Co., Inc. (MRK) trades at $145.78 on $359.40B of equity value, with a trailing P/E of 148.79. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.
MRK price $145.78 -2.27 -1.53%
Stocklytics score rationale: value 31, quality 61, growth 26.
AI Score 55. Merck & Co., Inc. has a high price-to-earnings ratio of approximately 153.4, indicating overvaluation relative to earnings
Merck & Co., Inc. operates in the Healthcare sector and Drug Manufacturers - General industry. The shares offer a dividend yield of 2.3%.
The stock trades at a P/E ratio of 151.4 and a price-to-book ratio of 8.8. These multiples indicate a demanding valuation based on the provided measures.
Net margin is 3.6%, indicating profitability, though the provided information does not include balance-sheet, cash-flow, or return metrics.
No revenue, earnings-growth, estimate-revision, or price-trend data are provided, so growth cannot be assessed from the available facts.
The elevated P/E ratio of 151.4 creates valuation risk if earnings do not support the multiple. The net margin of 3.6% also provides limited evidence of profitability strength without additional operating context.
Insights · Dividends · Forecast · Financials · Learn